Clinical Trials Directory

Trials / Completed

CompletedNCT01771913

Immunophenotyping of Fresh Stromal Vascular Fraction From Adipose Derived Stem Cells (ADSC) Enriched Fat Grafts

Immunophenotyping of Fresh Stromal Vascular Fraction From Adipose Derived Stem Cells (ADSC) Enriched Fat Grafts for Refinements of Reconstructed Breasts

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
Female
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate if there is a relationship between the take of fat grafts with and without ADSCs and the presence of specific surface markers on the cells of the stromal vascular fraction.

Detailed description

Two groups of patients will be studied. The control will receive centrifuged fat grafts while the other group will receive centrifuged enriched fat grafts with ADSCs. The performance of both grafts will be assessed through volume measurement employing MRI before and after 6 months post-op.

Conditions

Interventions

TypeNameDescription
GENETICcentrifuged fat graftfat from the abdominal subcutaneous tissue will be taken by vacuum assisted lipectomy and immediately prepared to be grafted in the reconstructed breast that presents contour irregularities and/or volume insufficiency. No adipose derived stem cells will enrich the fat grafts in this group.
GENETICADSCs enriched fat graftfat from the abdominal subcutaneous tissue will be taken by suction assisted lipectomy and stromal vascular fraction will be isolated and immediately added to the fat graft that will be employed to improve contour irregularities and volume insufficiency of reconstructed breasts.

Timeline

Start date
2012-03-01
Primary completion
2014-09-01
Completion
2015-05-01
First posted
2013-01-18
Last updated
2015-08-24
Results posted
2015-08-24

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01771913. Inclusion in this directory is not an endorsement.